Abstract
Extranodal NK/T-cell lymphoma is a recently recognized distinct entity within the World Health Organization classification of lymphoid tumors. It is relatively prevalent in Asian and South American populations. It most commonly occurs in the nasal or paranasal areas and less frequently in the skin, the soft tissue, and the gastrointestinal tract. Among these, extranodal NK/T-cell lymphoma of the gastrointestinal tract has shown an aggressive clinical course. We report a case of CD56+ extranodal NK/T-cell lymphoma presenting as a duodenal ulcer bleeding. A 62-year-old male patient presented with melena and abdominal pain. Endoscopic examination of the upper gastrointestinal tract showed the duodenal ulcer covered by blood clot. Pathologic examination revealed the diffuse infiltration of atypical lymphocytes with an angiocentric growth pattern, which was positive for CD3, CD56, and granzyme. The patient showed rapid deteriorating clinical course and died on day 14 after admission. Thus, we report this case with the review of literatures.
REFERENCES
1. Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol. 2005; 12:27–34.
2. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol. 2007; 139:532–544.
3. Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol. 2008; 26:66–72.
4. Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS, Kim SW. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer. 2000; 89:2106–2116.
5. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005; 19:2186–2194.
6. Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007; 43:4–14.
7. Kim KJ, Lee GH, Hong SS, et al. A case of duodenal relapse of Epstein-Barr virus-positive, CD56-negative extranodal NK/T-cell lymphoma, nasal type. Korean J Gastrointest Endosc. 2005; 30:204–209.
8. Sumi M, Tauchi T, Sashida G, et al. Natural killer cell lymphoma in the duodenum. Leukemia and Lymphoma. 2003; 44:201–204.
9. Tsuzuki Y, Okamoto S, Takayama N, et al. Natural killer-like T-cell lymphoma appearing in the duodenum with recurrence in a variety of extranodal organs. Rinsho Ketsueki. 1999; 40:494–498.
10. Kim JH, Lee JH, Lee J, et al. Primary NK-/T-cell lymphoma of the gastrointestinal tract: clinical characteristics and endoscopic findings. Endoscopy. 2007; 39:156–160.
11. Ko YH, Cho EY, Kim JE, et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology. 2004; 44:480–489.
12. Cogliatti SB, Schmid U. Who is WHO and what was REAL? Swiss Med Wkly. 2002; 132:607–617.
13. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992; 79:2432–2437.
14. Wong KF, Chan JK, Ng CS, Lee KC, Tsang WY, Cheung MM. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocen-tricity. Hum Pathol. 1992; 23:798–804.
15. Kim TM, Lee SY, Jeon YK, et al. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol. 2008; 19:1477–1484.
18. Musshoff K, Schmidt-Vollmer H. Proceedings: prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975; 83:323–341.